These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 30279047)
1. A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy. McDowell LJ; Ringash J; Xu W; Chan B; Lu L; Waldron J; Rock K; So N; Huang SH; Giuliani M; Hope A; O'Sullivan B; Bratman SV; Cho J; Kim J; Jang R; Bayley A; Bernstein LJ Radiother Oncol; 2019 Feb; 131():179-185. PubMed ID: 30279047 [TBL] [Abstract][Full Text] [Related]
2. Multi-domain neurocognitive impairment following definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A cross-sectional study. Chow JCH; Lee J; Lai MMP; Li S; Lau AMC; Ng BSY; Leung GGG; Li STY; Lui JCF; Cheung KM; Au KH; Wong KH; Lau AYL; Zee BCY Radiother Oncol; 2024 Apr; 193():110143. PubMed ID: 38341098 [TBL] [Abstract][Full Text] [Related]
3. Cognitive function, mood, and sleep quality in patients treated with intensity-modulated radiation therapy for nasopharyngeal cancer: a prospective study. Mo YL; Li L; Qin L; Zhu XD; Qu S; Liang X; Wei ZJ Psychooncology; 2014 Oct; 23(10):1185-91. PubMed ID: 24729515 [TBL] [Abstract][Full Text] [Related]
4. Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy. McDowell LJ; Rock K; Xu W; Chan B; Waldron J; Lu L; Ezzat S; Pothier D; Bernstein LJ; So N; Huang SH; Giuliani M; Hope A; O'Sullivan B; Bratman SV; Cho J; Kim J; Jang R; Bayley A; Ringash J Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):340-352. PubMed ID: 30191868 [TBL] [Abstract][Full Text] [Related]
5. The Prevalence and Determinants of Return to Work in Nasopharyngeal Carcinoma Survivors. So N; McDowell LJ; Lu L; Xu W; Rock K; Waldron J; Bernstein LJ; Chan HB; Huang SH; Giuliani M; Hope A; O'Sullivan B; Bratman SV; Cho J; Kim J; Jang R; Bayley A; Ringash J Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):134-145. PubMed ID: 31568813 [TBL] [Abstract][Full Text] [Related]
6. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy. Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548 [TBL] [Abstract][Full Text] [Related]
7. Fatigue following radiation therapy in nasopharyngeal cancer survivors: A dosimetric analysis incorporating patient report and observer rating. MD Anderson Head Neck Cancer Symptom Working Group Radiother Oncol; 2019 Apr; 133():35-42. PubMed ID: 30935579 [TBL] [Abstract][Full Text] [Related]
8. Remote assessment of cognition and quality of life following radiotherapy for nasopharyngeal carcinoma: deep-learning-based predictive models and MRI correlates. Voon NS; Manan HA; Yahya N J Cancer Surviv; 2024 Aug; 18(4):1297-1308. PubMed ID: 37010777 [TBL] [Abstract][Full Text] [Related]
9. Cross-sectional study of patient-reported neurobehavioral problems following hematopoietic stem cell transplant and health-related quality of life. Wu LM; Austin J; Valdimarsdottir H; Isola L; Rowley SD; Diefenbach MA; Cammarata M; Redd WH; Rini C Psychooncology; 2014 Dec; 23(12):1406-14. PubMed ID: 24846770 [TBL] [Abstract][Full Text] [Related]
10. Comparison of long-term quality of life and their predictors in survivors between paediatric and adult nasopharyngeal carcinoma in the intensity-modulated radiotherapy era. Jin J; Guo SS; Liu LT; Wen DX; Liu RP; Lin JY; Liu SQ; Sun XS; Liang YJ; Tang LQ; Mai HQ; Chen QY BMC Cancer; 2024 Oct; 24(1):1223. PubMed ID: 39358733 [TBL] [Abstract][Full Text] [Related]
11. Cognitive function before and after intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: a prospective study. Hsiao KY; Yeh SA; Chang CC; Tsai PC; Wu JM; Gau JS Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):722-6. PubMed ID: 20044217 [TBL] [Abstract][Full Text] [Related]
12. Cognitive process scores associated with self-reported behavioral dysfunction on the Frontal Systems Behavior Scale (FrSBe) in chronic traumatic brain injury. Smith EE; Smith JAD; Juengst SB J Clin Exp Neuropsychol; 2020 Feb; 42(1):90-100. PubMed ID: 31599186 [No Abstract] [Full Text] [Related]
13. Neurobehavioral Disturbances During Acute and Early HIV Infection. Kamat R; Doyle KL; Iudicello JE; Morgan EE; Morris S; Smith DM; Little SJ; Grant I; Woods SP; Cogn Behav Neurol; 2016 Mar; 29(1):1-10. PubMed ID: 27008244 [TBL] [Abstract][Full Text] [Related]
14. Late toxicity, evolving radiotherapy techniques, and quality of life in nasopharyngeal carcinoma. Lastrucci L; Bertocci S; Bini V; Borghesi S; De Majo R; Rampini A; Pernici P; Gennari PG Radiol Med; 2017 Apr; 122(4):303-308. PubMed ID: 28070838 [TBL] [Abstract][Full Text] [Related]
15. Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy. Chen AM; Daly ME; Farwell DG; Vazquez E; Courquin J; Lau DH; Purdy JA JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):129-33. PubMed ID: 24337483 [TBL] [Abstract][Full Text] [Related]
16. The relationship between self-awareness of neurobehavioral symptoms, cognitive functioning, and emotional symptoms in multiple sclerosis. Goverover Y; Chiaravalloti N; DeLuca J Mult Scler; 2005 Apr; 11(2):203-12. PubMed ID: 15794396 [TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques. Fang FM; Tsai WL; Chen HC; Hsu HC; Hsiung CY; Chien CY; Ko SF Cancer; 2007 Jan; 109(2):313-21. PubMed ID: 17154159 [TBL] [Abstract][Full Text] [Related]
18. Cognitive dysfunctions and psychological symptoms in migraine without aura: a cross-sectional study. Santangelo G; Russo A; Trojano L; Falco F; Marcuccio L; Siciliano M; Conte F; Garramone F; Tessitore A; Tedeschi G J Headache Pain; 2016 Dec; 17(1):76. PubMed ID: 27568039 [TBL] [Abstract][Full Text] [Related]
19. Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013. Zhang LL; Li GH; Li YY; Qi ZY; Lin AH; Sun Y Cancer Res Treat; 2019 Jul; 51(3):982-991. PubMed ID: 30309219 [TBL] [Abstract][Full Text] [Related]
20. Olfactory change after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Wang JJ; Liang KL; Twu CW; Lin JC; Jiang RS Int Forum Allergy Rhinol; 2015 Nov; 5(11):1059-62. PubMed ID: 26077632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]